Personalized approach to prostate cancer prognosis

Area of Science:

• Oncology
• Pathology
• Medical Informatics

Background:

• Personalized medicine for prostate cancer integrates patient factors (age, genetics, comorbidities) with clinical variables (PSA, imaging, biopsy/prostatectomy features).
• Current risk assessment often relies on basic prognosticators (stage, grade, PSA) and clinical judgment, lacking routine ancillary diagnostic studies for treatment refinement.
• Prostate cancer management lags behind other cancers like breast cancer in utilizing ancillary diagnostic studies for personalized treatment decisions.

Purpose of the Study:

• To review current predictive statistical modeling in prostate cancer management.
• To explore the role of technical advances in functional histology in developing patient-specific risk profiles.
• To highlight the incorporation of a systems-based platform for improved clinical decision-making.

Main Methods:

• Review of current practices in predictive statistical modeling for prostate cancer.
• Analysis of technical advancements in functional histology.
• Discussion of systems-based platforms for risk profiling.

Main Results:

• Existing nomograms interrogate multiple variables, but clinical practice often simplifies risk assessment.
• Functional histology offers new avenues for detailed analysis of biopsy and prostatectomy specimens.
• Systems-based platforms are emerging for integrating diverse data for patient-specific risk profiles.

Conclusions:

• Enhanced functional histology can significantly improve the accuracy of patient-specific risk profiles in prostate cancer.
• Integrating advanced diagnostic techniques into a systems-based approach is crucial for refining treatment decisions.
• Future directions involve leveraging technical advances for more precise and personalized prostate cancer management.